Skip to main content
. 2020 Oct 19;2020(10):CD012859. doi: 10.1002/14651858.CD012859.pub2

Jee 2010.

Study characteristics
Methods Study design: randomized controlled trial
Study grouping: 2 groups, combination prophylaxis
Participants Baseline characteristics
Dexamethasone + ondansetron (group O)
  • Assessed for eligibility (n): ‐

  • Enrolled (n): ‐

  • Randomized (n): 50

  • Received treatment (n): 50

  • Analysed (n): 50

  • Age (mean ± SD, median (IQR), median (range)): 37.1 ± 3.3

  • Weight (mean ± SD, median (IQR), median (range)): 60.2 ± 8.9

  • BMI (mean ± SD, median (IQR), median (range)): NA

  • ASA I/II/III/IV (n): 47/3/0/0

  • Gender (female in %): 100

  • Non‐smoker (%): 96

  • History of PONV/motion sickness (%): 24

  • Type of general anaesthesia: inhalational anaesthesia (sevoflurane, N₂O)

  • Duration of anaesthesia or surgery (in min; as mean or median): 110.5

  • Use of perioperative opioids (if yes, which?): fentanyl PCA

  • Type of surgery: gynaecological operation (laparoscopy/laparotomy)


Dexamethasone + metoclopramide (group M)
  • Assessed for eligibility (n): ‐

  • Enrolled (n): ‐

  • Randomized (n): 50

  • Received treatment (n): 50

  • Analysed (n): 50

  • Age (mean ± SD, median (IQR), median (range)): 38.7 ± 3.2

  • Weight (mean ± SD, median (IQR), median (range)): 61.6 ± 6.8

  • BMI (mean ± SD, median (IQR), median (range)): NA

  • ASA I/II/III/IV (n): 48/2/0/0

  • Gender (female in %): 100

  • Non‐smoker (%): 94

  • History of PONV/motion sickness (%): 26

  • Type of general anaesthesia: inhalational anaesthesia (sevoflurane, N₂O)

  • Duration of anaesthesia or surgery (in min; as mean or median): 118.3

  • Use of perioperative opioids (if yes, which?): fentanyl PCA

  • Type of surgery: gynaecological operation (laparoscopy/laparotomy)


Included criteria: female, adult, ASA I and II, undergoing gynaecological operation with IV‐PCA
Excluded criteria: hypersensitivity to metoclopramide, ondansetron or dexamethasone, use of antiemetic drugs, presence of extrapyramidal motor disease, current steroid medication, liver or renal disease, peptic ulcer
Pretreatment: baseline characteristics (age, weight, ASA): no. Potential effect modifiers (gender, duration of anaesthesia, non‐smoker, history of PONV/motion sickness): no; (perioperative opioids): unclear
Interventions Intervention characteristics
Dexamethasone + ondansetron (group O)
  • Dose: dexamethasone 5 mg, ondansetron 4 mg

  • Time point of administration: dexamethasone after tracheal intubation, ondansetron at end of surgery

  • Route of administration: IV

  • Rescue antiemetics (if yes, which?): ondansetron 1 mg IV


Dexamethasone + metoclopramide (group M)
  • Dose: dexamethasone 5 mg, metoclopramide 20 mg

  • Time point of administration: dexamethasone after tracheal intubation, metoclopramide at end of surgery

  • Route of administration: IV

  • Rescue antiemetics (if yes, which?): ondansetron 1 mg IV

Outcomes Vomiting (6 to 12 hours)
  • Outcome type: dichotomous outcome


Arrhythmia (0 to 36 hours)
  • Outcome type: dichotomous outcome


Extrapyramidal symptoms (0 to 36 hours)
  • Outcome type: dichotomous outcome


Adverse events (general notes in the publication, 24 hours' observation)
  • Outcome type: general notes on side effects

Identification Sponsorship source: NA
Country: Korea
Setting: single‐centre, inpatient
Author's name: Hea‐Jo Yoon
Institution: Department of Anesthesiology and Pain Medicine, Cheil General Hospital and Women Healthcare Center, Kwandong University College of Medicine, Seoul, Korea
Email: heajo7890@hanmail.net
Address: Cheil General Hospital and Women Healthcare Center, Kwandong University College of Medicine, 1‐19, Mukjeong‐dong, Jung‐gu, Seoul 100‐380, Korea
Duration of study: NA
Language: English
Study's primary outcome: NA
Trial registry number: NA
Notes None
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk Quote: "using computer generated random numbers"
Allocation concealment (selection bias) Unclear risk Judgement comment: no statement
Blinding of participants and personnel (performance bias)
All outcomes Unclear risk Judgement comment: no statement
Blinding of outcome assessment (detection bias)
All outcomes Unclear risk Judgement comment: no statement
Incomplete outcome data (attrition bias)
All outcomes Low risk Judgement comment: no missing outcome data
Selective reporting (reporting bias) Unclear risk Judgement comment: no reference to a study protocol or trial registry number reported
Other bias Unclear risk Quote: "there were no significant differences in age, body weight, height, ASA, or PONV risk factors between groups (Table 1)"
Judgement comment: baseline characteristics (age, weight, ASA): no. Potential effect modifiers (gender, duration of anaesthesia, non‐smoker, history of PONV/motion sickness): no; (perioperative opioids): unclear